Pretrial Orders Issued in Taxotere Hair Loss MDL
The Taxotere permanent hair loss MDL is continuing to move forward  Pretrial Orders in Taxotere Hair Loss MDL. The Taxotere permanent hair loss multidistrict litigation (MDL) is continuing to move forward, as several pretrial orders have been issued. On Jan. 19, 2017, the court issued its 12th Pretrial Order requiring that … [Read more...]
Women Struggle with Permanent Hair Loss After Taxotere Chemotherapy
Taxotere (Docetaxel) Chemotherapy Drug May Lead to Permanent Hair Loss Taxotere Chemotherapy Drug Side Effects. Taxotere (Docetaxel) Chemotherapy Drug May Lead to Permanent Hair Loss. For some patients who have been treated with the chemotherapy drug Taxotere (docetaxel), the usual physical and emotional effects of … [Read more...]
Taxotere Permanent Hair Loss Devastates Patients
Taxotere alopecia (hair loss) has been permanent Taxotere (docetaxel) received U.S. Food and Drug Administration (FDA) approval in 1996. Sanofi, Aventis Pharma SA in France and Sanofi-Aventis US LLC in the United States promoted Taxotere as an effective chemotherapy medication for cancer patients. Taxotere was touted for … [Read more...]
Propecia Side Effects Worse for Men with Neurobiological Abnormalities
Propecia Side Effects For Men. The drug Propecia (finasteride) is a very effective hair loss treatment for men. But the drug has been linked serious side effects including sexual function and fertility disorders, disorders, mood disorders, suicidal thoughts, and suicides. According to the Post-Finasteride Syndrome Foundation (PFS … [Read more...]
Taxotere Permanent Alopecia
Taxotere is likelier to lead to permanent alopecia Chemotherapy Agent, Taxotere, Associated with Permanent Hair Loss. Taxotere (docetaxel) is a breast cancer medication marketed by Sanofi-Aventis and is often administered in collaboration with other cancer drugs. Since its approval by the U.S. Food and Drug Administration in … [Read more...]
Taxotere May Lead to Permanent Hair Loss
Cancer survivors who were prescribed Taxotere by their oncologist could suffer permanent hair loss. Hair loss, called Alopecia, is expected when taking a chemotherapy drug. However, a cancer victim’s hair typically regrows within three or four months after stopping the chemotherapy regimen. Survivors who took Taxotere could suffer a … [Read more...]
Breast Cancer Survivor Files Lawsuit over Permanent Hair Loss
A breast cancer survivor is suing the makers of Taxotere File Suit Against Chemotherapy Drug Maker After Patients Suffered Permanent Hair Loss. A breast cancer survivor is suing the makers of the chemotherapy drug Taxotere (docetaxel) because she has suffered permanent hair loss after chemotherapy. The plaintiff, Carole, was … [Read more...]
Lawsuits Filed when Permanent Chemotherapy Hair Loss is Linked to Taxotere
Breast cancer patients are usually familiar with the likely side effect of chemotherapy of hair loss. Most, however, expect that hair grows back once the chemotherapy is over. However, an increasing number of breast cancer patients are finding that this is not always the case after they have taken certain drugs. Sanofi Aventis, … [Read more...]
New Lawsuit Filed over Taxotere Alleges Permanent Hair Loss
Sanofi-Aventis is facing a new lawsuit filed over Taxotere, a chemotherapy drug used to treat breast cancer and other forms of cancer. The suit, filed on behalf of a Mississippi woman, alleges that the drug resulted in alopecia, or permanent hair loss. The suit focuses on the alleged lack of warning. The plaintiff started taking … [Read more...]
11-Year-Old Girl Goes Nearly Bald After Using Wen Hair Product
An 11-year-old girl suffered hair loss and went nearly bald after using Wen cleansing conditioner, but she isn’t the only one. More than 21,000 complaints have been filed over celebrity hairstylist Chaz Dean’s line of Wen hair products alleging hair loss, hair breakage and other issues. In the young girl’s case, she noticed large … [Read more...]
FDA Investigates Wen Hair Care Products
A class-action lawsuit has been filed against Wen Hair Care products and their distributor, Guehy-Renker, for allegedly causing hair loss (alopecia). More than 21,000 complaints have been received against Wen, sold by Hollywood hairstylist Chaz Dean. The U.S. Food and Drug Administration (FDA) is investigating claims ranging from … [Read more...]
Permanent Hair Loss Linked To Taxotere Breast Cancer Treatment
Hair Loss Linked To Taxotere. A number of women undergoing chemotherapy for breast cancer have recently come forward naming Taxotere (docetaxel) as a possible cause for their apparent permanent hair loss. Many have filed lawsuits against Taxotere’s manufacturer, Sanofi-Aventis. Patients are attracted to Taxotere as it is received … [Read more...]
Taxotere and the Risk of Alopecia
The U.S. Food and Drug Administration (FDA) approved Taxotere as a chemotherapy drug in 1996. Taxotere is manufactured by Sanofi-Aventis and is commonly used to treat breast cancer, as well as other cancers. Some patients taking Taxotere have reported experiencing permanent hair loss, or alopecia. In December 2015, the FDA warned … [Read more...]
Questions about Sexual Side Effects of Hair-Loss Drug
A review of 34 clinical trials on a popular drug to treat hair loss in men found that none of the studies adequately reported on the drug’s sexual side effects. The findings raise serious questions about whether finasteride, marketed as Propecia and Proscar, among other names, is safe, according to the report by scientists at … [Read more...]
